Levetiracetam Intrapharm Laboratories

Levetiracetam, the active ingredient in Levetiracetam Intrapharm Laboratories, is an anticonvulsant presented as a intravenous solution for intravenous use. It treats partial‑onset, myoclonic, and primary generalized tonic‑clonic seizures as adjunct therapy in patients with epilepsy.

GNH USA supplies Levetiracetam Intrapharm Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent used as adjunct therapy for several seizure types.

- Partial‑onset seizures: reduces seizure frequency when added to existing therapy. - Myoclonic seizures: helps control rapid, brief muscle jerks in appropriate patients. - Primary generalized tonic‑clonic seizures: decreases seizure occurrence as part of combination treatment.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness: transient sensation of lightheadedness or unsteadiness. - Fatigue: feeling unusually tired or low energy. - Headache: mild to moderate head pain. - Irritability: increased agitation or mood changes.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare skin and mucous membrane disorder. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests periodically. - Psychiatric history: observe for mood changes or depression. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may decrease levetiracetam exposure. - Phenobarbital: can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels modestly. - Rifampin: may enhance clearance of levetiracetam. - Oral contraceptives: monitor for reduced efficacy of contraceptives.